Navigation Links
Director's Forum: PEPFAR and the Global AIDS Response
Date:9/17/2007

To be webcast live at http://www.wilsoncenter.org/globalhealth

WASHINGTON, Sept. 17 /PRNewswire-USNewswire/ -- Earlier this year, President George W. Bush called for a reauthorization of the President's Emergency Plan for AIDS Relief (PEPFAR), which is set to expire at the end of fiscal year 2008. The plan calls for an increase in funding from the initial 2003 commitment of $15 billion to $30 billion over the next five years.

On September 20, 2007, the Woodrow Wilson Center's Global Health Initiative and Environmental Change and Security Program will co-host a discussion on PEPFAR principles and the global AIDS response, featuring Dr. Peter Piot, Executive Director of UNAIDS and Under Secretary-General of the United Nations, U.S. Representative Nita M. Lowey of New York's 18th District, and Kent R. Hill, Assistant Administrator for the Bureau for Global Health at the U.S. Agency for International Development (USAID).

If you are unable to attend, this event will be webcast live at http://www.wilsoncenter.org/globalhealth.

What: Director's Forum: PEPFAR and the Global AIDS Response

Who: Dr. Peter Piot, Executive Director, UNAIDS, and Under

Secretary-General, United Nations; The Honorable Nita M.

Lowey, U.S. Representative, 18th District, New York, and

Chairwoman of the State, Foreign Operations, and Related

Programs Subcommittee on Appropriations; and Kent R. Hill,

Assistant Administrator for Global Health, USAID

When: Thursday, September 20, 2007, 10:00 - 11:30 a.m.

Where: Woodrow Wilson Center, 6th Floor Flom Auditorium

The Woodrow Wilson Center is located in the Ronald Reagan

Building and International Trade Center at 1300 Pennsylvania

Avenue, N.W.

Space is limited; please RSVP to globalhealth@wilsoncenter.org with your name and affiliation. Media with questions should contact Sharon McCarter at sharon.mccarter@wilsoncenter.org or (202) 691-4016.

The Woodrow Wilson International Center for Scholars is the living, national memorial to President Wilson established by Congress in 1968 and headquartered in Washington, D.C. The Center establishes and maintains a neutral forum for free, open, and informed dialogue. It is a nonpartisan institution, supported by public and private funds and engaged in the study of national and world affairs.


'/>"/>
SOURCE Woodrow Wilson International Center for Scholars
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
2. New Report Looking at Chiral Technologies Analyzes the Global Market Growth Forecasts Driven By Two Very Important Components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals
3. New Study Reveals Limitations of a Complex and Challenging Global Tuberculosis Drug Marketplace
4. Global Rabies Treatment May be Possible with NanoViricides Drugs
5. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
6. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
7. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
8. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
9. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
10. Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
11. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/13/2018)... ... September 13, 2018 , ... ... on developing and commercializing gastrointestinal therapeutics, has secured acceptance of Camligo™ as ... and Drug Administration (FDA) and European Medicines Agency (EMA), have accepted Camligo™ ...
(Date:9/12/2018)... DALLAS (PRWEB) , ... September 12, 2018 , ... ... to senior living communities, announces the launch of a new online store to offer ... of all ages. , “We’re thrilled to open our online store to offer ...
(Date:9/7/2018)... ... September 06, 2018 , ... This year, the California Society of Plastic ... presentation of: IDEAL IMPLANT® - Seven-Year Clinical Trial Results at the 68th CSPS Annual ... the upcoming ASPS (American Society of Plastic Surgeons) meeting in Chicago this fall. , ...
Breaking Medicine Technology:
(Date:8/31/2018)... ... 2018 , ... Becker's Healthcare is pleased to release the ... hospitals as well as facilities affiliated with large health systems. Some hospitals serve ... The hospitals continue to grow in many communities, opening new departments and sites ...
(Date:8/31/2018)... EAST HANOVER (PRWEB) , ... August 31, 2018 ... ... has expanded its neuroimaging capabilities with the addition of an MRI Simulator. In ... imaging (MRI) scan including sounds. By engaging in this mock scan experience, research ...
(Date:8/31/2018)... Pa. (PRWEB) , ... August 31, 2018 , ... ... those offered by the American Heart Association (AHA) to be responsive for procurement ... concerns and purchasing managers may now reap the benefits. Companies like Pacific Medical ...
(Date:8/31/2018)... ... August 31, 2018 , ... Rudina Thanasi, a ... a biofield energy treated nutraceutical to improve overall immunity and to combat inflammatory ... blood, as well as, inflammation. The following data was reported:, ...
(Date:8/31/2018)... ... 2018 , ... Saturday, September 1st, 2018, Team Fastrax™ will perform their fan ... opener game. At 7pm, the Cyclones will kick off against the South Dakota State ... Fastrax™ will jump in with their majestic 2,000 sq. ft. American Flag, red white ...
Breaking Medicine News(10 mins):